← Evidence map

TrialRheumatology international2022

Comparison between leflunomide and sulfasalazine based triple therapy in methotrexate refractory rheumatoid arthritis: an open-label, non-inferiority randomized controlled trial.

Pooja J Belani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2022
2023
2024
2025
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34586472